When is being in a hurry going too fast? Lessons learned from clinical trials in cervical cancer-Reference-Cited by-同舟云学术

When is being in a hurry going too fast? Lessons learned from clinical trials in cervical cancer

Published:2009-04 Issue:1 Volume:113 Page:1-3
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Monk Bradley J,Ali Shamshad,Gaffney David K.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference22 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J. Clin.,2005

2. http://www.gcig.igcs.org/.

3. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study;Monk;J. Clin. Oncol.,2009

4. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group study;Rose;J. Clin. Oncol.,2007

5. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N. Engl. J. Med.,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sentinel Amenable Mortality: A New Way to Assess the Quality of Healthcare by Examining Causes of Premature Death for Which Highly Efficacious Medical Interventions Are Available;BioMed Research International;2018-09-02

2. Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer;Journal of Clinical Oncology;2010-08-01

3. Phase 1 Study of Tirapazamine in Combination With Radiation and Weekly Cisplatin in Patients With Locally Advanced Cervical Cancer;International Journal of Gynecologic Cancer;2010-06

4. Anti-angiogenesis agents in metastatic or recurrent cervical cancer;Gynecologic Oncology;2010-02